Introduction
============

Labeling bacterial strains using fluorescent proteins has been used in manifold investigations, such as the study of biofilm formation, bacterial individuality and evolution, and bacterial behavior in complex environments (e.g., plant surfaces, soil, or the mammalian gut) ([@B67], [@B67]; [@B39]; [@B28]; [@B66]; [@B16]; [@B49]; [@B70]; [@B51]). Such studies require the equipment of bacteria with bright, stable, fast maturing, and highly abundant fluorescent proteins, which ideally offer unique spectral properties to unambiguously distinguish between differently labeled fluorescent bacteria. This is especially true during non-invasive *in situ* studies without additional staining procedures, such as fluorescence *in situ* hybridization, and where autofluorescence and low signal-to-noise ratio might hinder observations ([@B51]).

To date, several mechanisms have been described by which fluorescent protein genes can be delivered into bacterial cells and/or integrated into their chromosomes ([@B1]; [@B8]; [@B37]; [@B31]; [@B10]; [@B29]; [@B33]; [@B55]; [@B5]; [@B46]). Plasmids are attractive tools for fluorescent protein expression in bacteria, as they can be easily delivered into host cells and lead to high fluorescent protein production due to their presence in multiple copies ([@B38]). Plasmid stability usually requires a continuous selection (e.g., antibiotics; [@B2]) and, while only some plasmids were found to be maintained in bacterial populations without the pressure exerted by antibiotics ([@B8]; [@B53]), the absence of a selective pressure was reported to lead to plasmid loss in growing bacterial populations ([@B65]; [@B60]; [@B32]). However, some experimental systems are not compatible with the use of antibiotics as a selective pressure. In natural environments, bacteria often occur as biofilms, where cells are fixed in space and enclosed in an extracellular polymeric substance matrix. Within a biofilm, individual cells experience heterogeneous environments, and owing to their location, they might either be exposed to or protected from antibiotic pressure ([@B62]).

To overcome the disadvantage of plasmid loss or their inability to replicate in some hosts, chromosomal insertion of fluorescent markers is advantageous. Chromosomal insertions cannot be lost in the same fashion as plasmids during division, and the probability of mutations that would disrupt the functionality of fluorescent protein genes is low. Several molecular tools and mechanisms exist to integrate chromosomal insertions into bacterial genomes, such as homologous recombination ([@B33]), CRISPR-Cas9 ([@B25]), Zinc-finger nucleases ([@B9]), or transposase-based systems ([@B52]; [@B35]; [@B44]).

Transposon systems can differ widely in their host specificity and mode of integration. For instance, the Tn*5* transposon has been shown to be functional in a wide range of Gram-negative bacteria and to randomly insert into their genomes with high efficiency ([@B52]). This ability has been exploited to generate random mutation libraries ([@B15]; [@B11]), but also to integrate fluorescent protein genes into bacterial genomes ([@B1]; [@B55]). In contrast to Tn*5* transposons, Tn*7* transposons only integrate into specific regions, such as the *att*Tn*7* site, in the host chromosome. Integration at *att*Tn*7* is mediated by four transposases, TnsA, B, C, and D and appears to be prevalent in phylogenetically diverse species ([@B10]; [@B36]; [@B42]). Even though the host range of Tn*7* transposons is limited compared to the Tn*5* transposon, it has the tremendous advantage that the insertion does not disrupt any genes and has been argued to have little effect on bacterial fitness ([@B17]).

Here, we developed three sets of plasmids, which contain genes encoding for the latest generation of fluorescent proteins, i.e., that have blue, cyan, green, yellow, orange, red, and far-red fluorescence emissions, with different degrees of spectral overlap. The fluorescent protein genes mTagBFP2 (mTB2), mTurquoise2 (mTq2), sGFP2, mClover3 (mCl3), sYFP2, mOrange2 (mO2), mScarlet-I (mSc), and mCardinal (mCa) were combined with four combinations of antibiotic resistance genes, i.e., gentamicin, kanamycin, tetracycline and/or chloramphenicol, on three different plasmid backbones: a broad host-range plasmid, a Tn*5* transposon delivery plasmid, and a Tn*7* transposon delivery plasmid (Figure [1](#F1){ref-type="fig"}). The broad host-range plasmid contains the pBBR1 origin of replication ([@B37]). The Tn*5* transposon plasmid pAG408 is based on an R6K origin of replication. It is a suicide plasmid that only replicates in presence of the π factor ([@B63]). The Tn*7* transposon plasmid pGRG36 is based on the thermo-unstable pSC101 origin of replication and is therefore a conditional suicide plasmid for species closely related to *Escherichia coli* and a suicide plasmid in all other bacteria ([@B36]). The expression of the fluorescence protein genes is driven by the *nptII* promoter of the neomycin phosphotransferase gene (i.e., kanamycin resistance gene). The *nptII* promoter is considered constitutive, strong and was previously used to drive fluorescent protein expression from chromosomal insertions ([@B33]; [@B45]). We demonstrate the delivery of plasmids and transposons in a broad phylogenetic background of recently isolated environmental bacteria. Furthermore, we show the heterologous expression of fluorescent proteins at the single-cell resolution in those environmental bacterial strains using fluorescence microscopy.

![Overview of cloning procedures. **(A)** Construction of the pMRE plasmid series. To obtain the pMRE13X plasmid series, HindIII-digested pPROBE-derived pFru97 was isothermally assembled with a fragment containing the *ntpII* promoter (P*ntpII*) and a fragment carrying one of eight fluorescent protein genes (FP) -- mTagBFP2, mTurquoise2, sGFP2, mClover3, sYFP2, mOrange2, mScarlet-I, and mCardinal. The rest of the pMRE series were constructed through the assembly of SacI-digested pMRE13X and one of three additional antibiotic resistance gene (AR) -- Gentamicin (Gent^R^), Kanamycin (Kan^R^), and Tetracycline (Tet^R^). **(B)** Construction of the transposon delivery plasmid series pMRE-Tn5 and pMRE-Tn7. PCR products using the pMRE plasmid series as templates containing AR, FP and a Chloramphenicol resistance (Cam^R^) were isothermally inserted into EcoRV digested pAG408 to yield the pMRE-Tn5 series. Similarly, PCR products containing AR, FP and a Chloramphenicol resistance (Cam^R^) were blunt-end cloned into SmaI digested pGRG36 to yield the pMRE-Tn7 series.](fmicb-09-03052-g001){#F1}

Materials and Methods {#s1}
=====================

Media and Growth Conditions
---------------------------

Bacterial strains and their growth media are shown in Table [1](#T1){ref-type="table"}. Growth media were prepared according to the manufacturer's recommendations and supplemented with 1.5% agar (Agar No.1, Oxoid) where commercial broth media was used as a base: lysogeny broth agar (LBA, Lysogeny broth Miller, Merck), tryptic soy broth agar (TSA, Merck), nutrient agar (NA, Nutrient broth, Oxoid), or Reasoner's 2a agar (R2A, HiMedia). *E. coli* carrying pMRE or pMRE-Tn5 plasmids were cultivated at 37°C, whilst pMRE-Tn7 plasmid-carrying cells were cultivated at 30°C to prevent plasmid loss. All other strains used in this study were cultivated at 30°C. For counterselection after conjugation, auxotroph *E. coli* S17-1 was grown on either MM2 agar medium ([@B72]) (4.0 g L^-1^ [L]{.smallcaps}-asparagine, 2.0 g L^-1^ K~2~HPO~4~, 0.2 g L^-1^ MgSO~4~ ⋅ 7H~2~O, 3.0 g L^-1^ NaCl, 10.0 g L^-1^ sorbitol, 15 g L^-1^ agar) or minimal agar medium ([@B23]) (1.62 g L^-1^ NH~4~Cl, 0.2 g L^-1^ MgSO~4~, 1.59 g L^-1^ K~2~HPO~4~, 1.8 g L^-1^ NaH~2~PO~4~ ⋅ 2H~2~O, 15 g L^-1^ agar, with the following trace elements: 15 mg L^-1^ Na~2~EDTA~2~ ⋅ H~2~O, 4.5 mg L^-1^ ZnSO~4~ ⋅ 7H~2~O, 3 mg L^-1^ CoCl~2~ ⋅ 6H~2~O, 0.6 mg L^-1^ MnCl~2~, 1 mg L^-1^ H~3~BO~3~, 3.0 mg L^-1^ CaCl~2~, 0.4 mg L^-1^ Na~2~MoO~4~ ⋅ 2H~2~O, 3 mg L^-1^ FeSO~4~ ⋅ 7H~2~O, and 0.3 mg L^-1^ CuSO~4~ ⋅ 5H~2~O) supplemented with 0.4% w/v succinate or glucose were used, depending on the recipient strain (Table [1](#T1){ref-type="table"}). Where appropriate, media were supplemented with antibiotics in the following concentrations: 100 mg L^-1^ ampicillin, 50 mg L^-1^ kanamycin, 20 mg L^-1^ gentamicin, 15 mg L^-1^ chloramphenicol, or 15 mg L^-1^ tetracycline.

###### 

Bacterial strains, their relevant naturally-occurring antibiotic resistances, standard growth media, and conditions for selection after conjugation experiments.

                                                                                                                                     Relevant                           
  ---------------------------------------------------------------------------------------------------------------------------------- ----------------- ---------------- --------------------------
  *E. coli* DH5α \[F- recA1 endA1 φ80lacZΔM15 supE44 thi-1 relA1 gyrA96 phoA Δ(lacZYA-argF)U169 hsdR17(rk-, mk+) tonA\]              n.a.              LBA              Thermo Fisher Scientific
  *E. coli* HST08 \[F- recA1 endA1 φ80lacZΔM15 supE4 thi-1 relA1 gyrA96 phoA Δ(lacZYA-argF)U169 Δ(mrr-hsdRMS-mcrBC) mcrA\]           n.a.              LBA              Stellar, Clontech
  *E. coli* Top10 \[F- recA1 endA1 φ80lacZΔM15 Δ(mrr-hsdRMS-mcrBC) ΔlacX74 araD139 Δ(araleu)7697 galU galK rpsL (StrR) nupG mcrA\]   n.a.              LBA              Thermo Fisher Scientific
  *E. coli* S17-1 \[F- recA1 endA1 Δpro-82 ΔhsdR RP4-2(Tc::Mu-1,Km::Tn7) λpir\]                                                      n.a.              LBA              
  *Acidovorax* sp. Leaf84                                                                                                            n.a.              NA/Succinate     [@B3]
  *Bradyrhizobium* sp. Leaf396                                                                                                       n.a               R2A/Succinate    [@B3])
  *Erwinia amylovora* CFBP1430S                                                                                                      n.a.              TSA/Succinate    [@B61]
  *Methylobacterium* sp. Leaf92                                                                                                      n.a.              R2A/Succinate    [@B3]
  *Microbacterium* sp. Leaf320                                                                                                       Gent^R^           NA/Glucose       [@B3]
  *Pantoea agglomerans* 299R                                                                                                         Cam^R^            TSA/Succinate    [@B48]
  *Pedobacter* sp. Leaf194                                                                                                           Gent^R^, Kan^R^   R2A/R2A + Gent   [@B3]
  *Pseudomonas syringae* B728a                                                                                                       Cam^R^            TSA/Succinate    [@B18]
  *Pseudomonas citronellolis* P3B5                                                                                                   Cam^R^            NA/Succinate     [@B47]
  *Sphingomonas melonis* FR1                                                                                                         n.a.              NA/Succinate     [@B24]
  *Rhodococcus* sp. Leaf225                                                                                                          n.a.              NA/Glucose       [@B3]

n.a., not applicable

.

Plasmid Construction
--------------------

All plasmids used or constructed in this study are shown in Table [2](#T2){ref-type="table"}. Generic plasmid maps and cloning procedures are presented in Figure [1](#F1){ref-type="fig"}. For plasmid construction, PCRs were performed using Phusion High-Fidelity DNA polymerase (Thermo Scientific) following the manufacturer's recommendations. Annealing temperatures (Ta) were chosen based on the respective melting temperature (*t*~m~) of the primers (Table [3](#T3){ref-type="table"}). Touchdown PCRs were performed to amplify PCR products with overlapping ends for isothermal assemblies. To that end, the initial Ta was set to 10°C above the lowest *t*~m~ of the respective primers and the Ta was gradually reduced 1°C per cycle for a total of 10 cycles. After the 10th cycle, a two-step PCR with Ta set to 72°C was performed for 25 cycles.

###### 

Plasmids used in this work.

  Name                              Notable features                          Source
  --------------------------------- ----------------------------------------- -------------------------
  pFru97(pPROBE)                    Kan^R^, Cam^R^                            [@B66]
  pGRG36                            Tn7 transposon, Amp^R^                    [@B36]
  pAG408                            Tn5 transposon, Amp^R^, Gent^R^, Kan^R^   [@B63]
  mTagBFP2-pBAD                     mTagBFP2                                  [@B64]
  pLifeAct-mTurquoise2              mTurquoise2                               [@B22]
  pMREtn5-Ptuf-sYFP2                sYFP2                                     Hans-Martin Fischer lab
  pNCS-mClover3                     mClover3                                  [@B4]
  mOrange2-pBAD                     mOrange2                                  Michael Davidson lab
  pTriEx-RhoA-wt_mScarlet-I_SGFP2   mScarlet-I, sGFP2                         [@B7]
  mCardinal-pBAD                    mCardinal                                 [@B12]
  pRJpahp-gfp+                      nptII promoter                            [@B33]
  pTE105-mChe                       Tet^R^                                    [@B55]
  pMRE13X                           Kan^R^, Cam^R^                            This work
  pMRE14X                           Kan^R^, Cam^R^, Gent^R^                   This work
  pMRE15X                           Kan^R^, Cam^R^, Kan^R^                    This work
  pMRE16X                           Kan^R^, Cam^R^, Tet^R^                    This work
  pMRE-Tn7-13X                      Tn7 transposon, Amp^R^, Cam^R^            This work
  pMRE-Tn7-14X                      Tn7 transposon, Amp^R^, Cam^R^, Gent^R^   This work
  pMRE-Tn7-15X                      Tn7 transposon, Amp^R^, Cam^R^, Kan^R^    This work
  pMRE-Tn7-16X                      Tn7 transposon, Amp^R^, Cam^R^, Tet^R^    This work
  pMRE-Tn5-13X                      Tn5 transposon, Amp^R^, Cam^R^            This work
  pMRE-Tn5-14X                      Tn5 transposon, Amp^R^, Cam^R^, Gent^R^   This work
  pMRE-Tn5-15X                      Tn5 transposon, Amp^R^, Cam^R^, Kan^R^    This work
  pMRE-Tn5-16X                      Tn5 transposon, Amp^R^, Cam^R^, Tet^R^    This work

X is a placeholder for either 0, 1, 2, 3, 4, 5, 6, or 7 representing mTagBFP2, mTurquoise, sGFP2, sYFP2, mOrange, mScarlet-I, mCardinal, or mClover3 encoding versions of the plasmids, respectively

.

###### 

Primer used in this work.

  Name             Target                                                                    Sequence 5′ to 3^′∗^                            *t*~m~ (°C)^\#^
  ---------------- ------------------------------------------------------------------------- ----------------------------------------------- -----------------
  FWD_PnptII       *nptII* promoter on pRJPaph_gfp+                                          aggaattggggatcggaTTCGAGCTCGCACGCTGCCG           64
  REV_PnptII_1     *nptII* promoter on pRJPaph_gfp+, overlap to mCa, mO2, mSc, sYFP2, mCl3   tgctcaccatTTTTCTTCCTCCACTAGTA                   47
  REV_PnptII_2     *nptII* promoter on RJPaph_gfp+, overlap to mTB2                          cttagacaccatTTTTTCTTCCTCCACTAGTA                47
  REV_PnptII_3     *nptII* promoter on pRJPaph_gfp+ with overlap to mTq2 and sGFP2           ccttgctcacTTTTTCTTCCTCCACTAGTA                  47
  FWD_FP1          mCardinal/mOrange2/mScarlet-I/sYFP2/mClover3                              ggaagaaaaaATGGTGAGCAAGGGCGAGGA                  60
  FWD_FP2          mTagBFP2                                                                  aggaagaaaaaATGGTGTCTAAGGGCGAAGA                 54
  FWD_FP3          mTurquoise2/sGFP2                                                         ggaagaaaaaGTGAGCAAGGGCGAGGAGCT                  61
  REV_FP1          mTurquoise2                                                               agtccaagctcagctaattaCTTGTACAGCTCGTCCATGC        54
  REV_FP2          sGFP2                                                                     agtccaagctcagctaattaCCCGGCGGCGGTCACGAACT        66
  REV_FP3          sYFP2                                                                     agtccaagctcagctaattaCTTACTTGTACAGCTCGTCC        52
  REV_FP4          mOrange2/mClover3                                                         agtccaagctcagctaattaTTACTTGTACAGCTCGTCCA        52
  REV_FP5          mScarlet-I/mCardinal                                                      agtccaagctcagctaattaGGAGGTCGCAGTATCTGGCC        58
  REV_FP6          mTagBFP2                                                                  agtccaagctcagctaattaATTAAGCTTGTGCCCCAGTT        54
  FWD_Gent         Gent^R^ on pAG408                                                         gggatcggattcgagctTTAGTACCTAGATTTAGATG           43
  REV_Gent         Gent^R^ on pAG408                                                         cagcgtgcgagctTTAGGTGGCGGTACTTGGGT               59
  FWD_Kan          Kan^R^ on pAG408                                                          gggatcggattcgagctAAGAATTCCCTTGGGGTAT            51
  REV_Kan          Kan^R^ on pAG408                                                          cagcgtgcgagctCTAAAACAATTCATCCAGTA               46
  FWD_Tet          Tet^R^ on pTE105-mChe                                                     ggggatcggattcgagctcTCAGCGATCGGCTCGTTGCC         63
  REV_Tet          Tet^R^ on pTE105-mChe                                                     cttgcggcagcgtgcgagctTCATGATAATAATGGTTTCTTA      46
  FWD_seq          Sequencing pMRE                                                           ATAAACTGCCAGGAATTGGGG                           56
  REV_seq          Sequencing pMRE                                                           CAACAGGAGTCCAAGCTCAG                            56
  FWD_pMRE-Tn5_1   pMRE fragment 1 with overlap to pAG408                                    ggctgcaggaattcgatatcCATAAACTGCCAGGAATTGGGGATC   59
  REV_pMRE-Tn5_1   pMRE fragment 1                                                           GCCATGTAAGCCCACTGCAAGCTAC                       63
  FWD_pMRE-Tn5_2   pMRE fragment 2                                                           GTAGCTTGCAGTGGGCTTACATGGC                       63
  REV_pMRE-Tn5_2   pMRE fragment 2 with overlap to pAG408                                    gtggcggtacttgggtcgatatcCTGGCGGCCGCAAGCTC        63
  FWD_pMRE-Tn7     pMRE fragment for Tn7                                                     ATAAACTGCCAGGAATTGGGG                           60
  REV_pMRE-Tn7     pMRE fragment for Tn7                                                     CTGGCGGCCGCAAGCTCC                              69
  FWD_Tn5/7_gt     Tn*5* and Tn*7* mutant genotyping                                         ATGGTGAGCAAGGGCGAG                              58
  REV_Tn5/7_gt     Tn*5* and Tn*7* mutant genotyping                                         CAACAGGAGTCCAAGCTCAG                            56
  FWD_Tn5_gt       Tn*5* mutant genotyping                                                   CTGAGTAGGACAAATCCGCCG                           58
  REV_Tn5_gt       Tn*5* mutant genotyping                                                   GCCTCGGCAGAAACGTTGG                             60
  FWD_Tn7_gt       Tn*7* mutant genotyping                                                   ACATAACGGACTAAGAAAAACACTACAC                    56
  REV_Tn7_gt       Tn*7* mutant genotyping                                                   GATCAACTCTATTTCTCGCGGG                          56
  Tn7_gt           Tn7 mutant genotyping                                                     GAATTACAACAGTACTGCGATGAG                        55

∗

Majuscules indicate complementary sequences to the original PCR target, minuscules indicate complementary sequences to the destination sequence.
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.

Several plasmids that were used as source for fluorescent protein genes were acquired from Addgene, a non-profit plasmid repository^1^: pGRG36 was a gift from Nancy Craig (Addgene plasmid \#16666). pTriEx-RhoA-wt_mScarlet-I_SGFP2 (Addgene plasmid \#85071) and pLifeAct-mTurquoise2 (Addgene plasmid \#36201) were gifts from Dorus Gadella. pNCS-mClover3 was a gift from Michael Lin (Addgene plasmid \#74236). Plasmids mCardinal-pBAD (Addgene plasmid \#54800) and mTagBFP2-pBAD (Addgene plasmid \#54572) were gifts from Michael Davidson and mOrange2-pBAD was a gift from Michael Davidson and Roger Tsien (Addgene plasmid \#54531). pMREtn5-Ptuf-sYFP2 was a gift from Raphael Ledermann and Hans-Martin Fischer. pFru97 was a gift from Johan Leveau ([@B66]). All plasmids that were used for PCR amplification were isolated using the DNA-spin plasmid DNA purification kit (INtRON biotechnology) following the manufacturer's recommendations. The designated plasmid backbones of the herein constructed plasmids, pFru97, pGRG36, and pAG408, were isolated using the Zyppy plasmid midiprep kit (Zymo) following the manufacturer's recommendations. Gel purification and PCR clean-up was performed using the Monarch DNA Gel Extraction Kit (NEB) or the DNA Clean & Concentrator-5 Kit (Zymo), respectively.

To construct the pMRE130 series, the promoter of the *nptII* gene (PnptII) was amplified from pRJPaph_gfp+ using primer FWD_PnptII, which contains overlapping sequences to HindIII-digested pFru97, and either primer REV_PnptII_1, REV_PnptII_2, or REV_PnptII_3, which contain overlapping sequences to the different fluorescent protein genes. The fluorescent protein genes were amplified using primer FWD_FP1, FWD_FP2, or FWD_FP3 with overlapping sequences to the PnptII fragment and primer REV_FP1, REV_FP2, REV_FP3, REV_FP4, REV_FP5, or REV_FP6 with overlapping sequences to HindIII-digested pFru97. The two resulting fragments were mixed with the HindIII-digested pFru97 backbone and isothermally assembled to yield plasmids pMRE130, pMRE131, pMRE132, pMRE133, pMRE134, pMRE135, pMRE136, and pMRE137. To construct the pMRE140 plasmid series, the gentamicin resistance gene (Gent^R^) was amplified from pAG408 using primers FWD_Gent and REV_Gent with overlaps to SacI-digested plasmids of the pMRE13X series, yielding pMRE140, pMRE141, pMRE142, pMRE143, pMRE144, pMRE145, pMRE146, and pMRE147. To construct the pMRE150 plasmid series, the kanamycin resistance gene (Kan^R^) was amplified from pAG408 using primers FWD_Kan and REV_Kan with overlapping sequences to SacI-digested plasmids of the pMRE13X series, yielding pMRE150, pMRE151, pMRE152, pMRE153, pMRE154, pMRE155, pMRE156, and pMRE157. To construct the pMRE16X plasmid series, the tetracycline resistance genes (Tet^R^) were amplified from pTE105-mChe using primers FWD_Tet and REV_Tet with overlapping sequences to SacI-digested plasmids of the pMRE13X series, yielding pMRE160, pMRE161, pMRE162, pMRE163, pMRE164, pMRE165, pMRE166, and pMRE167.

Isothermal assembly was performed as described previously ([@B21]; [@B6]; [@B46]). In short, plasmid backbones and inserts with overlapping sequences were mixed in a 1:3 molar ratio (20--100 ng backbone) to reach a total volume of 5 μL. Then, 15 μL of isothermal assembly mix were added and the reaction was incubated for 15 min at 50°C. Transformation of chemically competent *E. coli* strains was performed using standard procedures as recommended by the respective suppliers or as described in [@B54] (see Table [1](#T1){ref-type="table"}).

To construct the pMRE-Tn5 plasmid series, pMRE1XX plasmids were used as a template to amplify the desired DNA fragments, which include one of the eight fluorescent protein gene and one of the four antibiotic resistance marker combinations. Cassettes were amplified as two fragments using the primers FWD1_pMRE_pAG408 and RV1_pMRE_pAG408 or FWD2_pMRE_pAG408 and RV2_pMRE_pAG408. Primers FWD1_pMRE_pAG408 and RV2_pMRE_pAG408 contain overlapping sequences to EcoRV-digested pAG408. For isothermal assemblies, EcoRV-digested pAG408 was mixed with the insert fragments in a 1:3:3 ratio as described above and assembled plasmids were transformed into chemically competent *E. coli* S17-1.

To construct the pMRE-Tn7 family, fluorescent protein genes and antibiotic resistance genes were amplified from the pMRE1XX series using primers FWD_pMRE-Tn7 and REV_pMRE-Tn7. The amplicons were gel purified using the Monarch DNA Gel Extraction Kit (NEB) and phosphorylated using T4 polynucleotide kinase (Life Technologies). pGRG36 was SmaI digested and dephosphorylated using thermosensitive alkaline phosphatase according to the manufacturers' recommendations (Fast AP, Life Technologies). Following dephosphorylation, plasmids were purified using the DNA Clean & Concentrator^TM^-5 Kit (Zymo). Amplicons were then cloned into linearized and dephosphorylated pGRG36 using Quick-Stick T4 Ligase (Bioline). Ligations were purified using the DNA Clean & Concentrator^TM^-5 Kit and transformed into chemically competent *E. coli* (Top10, One Shot^TM^ MAX Efficiency^TM^ DH5^TM^α-T1R, or HST08).

All pMRE1XX series plasmids were verified by Sanger sequencing using primers FWD_seq and REV_seq at Macrogen (South Korea). pMRE-Tn5-1XX and pMRE-Tn7-1XX series plasmids were verified by PvuII restriction digests at 37°C for 1 h. To provide a convenient means of plasmid delivery, all plasmids were subsequently transformed into *E. coli* S17-1, which allows conjugations to recipient strains.

Conjugation
-----------

Recipients were grown on standard agar media for up to 4 days, depending on the growth rate of each environmental strain (see Table [1](#T1){ref-type="table"}). Donor strains *E. coli* S17-1 were grown overnight on LBA supplemented with either Kan or Amp to maintain pMRE or pMRE-Tn5 and pMRE-Tn7 plasmids, respectively (see Table [1](#T1){ref-type="table"}). Plasmids delivered into recipient strains include pMRE135, pMRE145, pMRE165, pMRE-Tn5-143, pMRE-Tn5-145, pMRE-Tn5-165, pMRE-Tn7-145, or pMRE-Tn7-165. Freshly grown bacteria were harvested using a loop and resuspended in 1× phosphate buffered saline (1×PBS; 8 g L^-1^ NaCl, 0.24 g L^-1^ KCl, 1.42 g L^-1^ Na~2~HPO~4~, 0.24 g L^-1^ KH~2~PO~4~) to reach an OD~600~ ~nm~ of 1. Each recipient strain was mixed with their respective donor strains in 1:1 ratio and the mix was then concentrated by centrifugation (4000 *g*, 5 min) to reach an estimated OD~600~ ~nm~ of 20. Bacterial mixes were drop spotted on NA and incubated for 18 h at 30°C. For conjugations using pMRE-Tn7, 0.1% w/v arabinose was added to the medium, as the Tn*7* transposase genes are under the control of an arabinose-inducible promoter. After incubation, the cells were harvested and resuspended in 1 mL 1× PBS. The bacterial mix was spread onto appropriate minimal agar media containing a sole carbon source (either 0.4% w/v succinate or 0.4% w/v glucose, see Table [1](#T1){ref-type="table"}) and appropriate antibiotics. Depending on the recipient strain, transconjugants appeared within 5--10 days. To further counterselect against *E. coli*, single colonies were restreaked at least twice onto fresh minimal media before growing them on complex media.

Validation of Transposon Insertion Events
-----------------------------------------

To provide a convenient tool to assess successful insertions of Tn*5* and Tn*7* transposons, a multiplex PCR was designed to determine the presence of plasmid backbones and fluorescent protein genes in one reaction. Primers FWD_Tn5/7_gt and RV_Tn5/7_gt were designed to amplify the fluorescent protein genes for both Tn*5* and Tn*7* delivery systems, while the combinations FWD_Tn5_gt and RV_Tn5_gt and FWD_Tn7_gt, RV_Tn7_gt, and Tn7_gt amplify a specific fragment of the backbone of Tn*5* and Tn*7* plasmids, respectively. For Tn*5* insertions, the primer mix FWD_tn5/7_gt, RV_tn5/7_gt, FWD_tn5_gt, and RV_tn5_gt was used. For Tn*7* insertions, primer mix FWD_tn5/7_gt and RV_tn5/7_gt and primer mix FWD_tn7_gt, RV_tn7_gt, and Tn7_gt were used. Reactions were performed using the KAPA2G Fast HotStart ReadyMix PCR kit (Kapa Biosystems) following the manufacturer's instructions.

Fluorescent Protein Absorption and Emission Spectra and Fluorescence Intensity
------------------------------------------------------------------------------

The absorption and emission spectra of the different proteins were measured in a Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies). To that end, overnight cultures of *E. coli* strains expressing the different fluorescent proteins were harvested by centrifugation (4000 *g*, 3 min), washed in 1× PBS and resuspended to reach an OD~600~ ~nm~ of 1. Then, 1 mL of each culture was measured in a polystyrene cuvette (VWR), except for cultures expressing mTagBFP2 and mCardinal, which were measured in a far-UV quartz cuvette (Agilent Technologies) due to their spectral properties. Absorption and emission were measured in the spectrophotometer in 1 nm intervals. The absorption and emission spectra of the proteins used in this study are available as "protein collection" on the webpage [fpbase.org](http://www.fpbase.org) (^[1](#fn01){ref-type="fn"}^[@B30]). This online platform allows for a convenient comparison of existing microscopy hardware and fluorophore properties.

To determine brightness of *E. coli* DH5α carrying plasmids or transposon insertions, respective strains were grown in eight biological replicates in LB broth (300 rpm, 37°C) to reach an OD~600~ ~nm~ of 1. Fluorescence intensity of cultures were measured in a flat bottom 96-well plate (Costar) using a FLUOstar Omega plate reader (BMG Labtech) equipped with an excitation filter (band pass 580/10) and an emission filter (band pass 620/10). Fluorescence intensity was corrected by background subtraction.

Fluorescence Microscopy and Image Processing
--------------------------------------------

Fluorescent protein-expressing *E. coli* were grown overnight in LB broth (210 rpm, 37°C). Cultures were harvested by centrifugation (4000 *g*, 3 min) and washed in 1× PBS. Bacterial cultures were resuspended in 1× PBS to an OD~600~ ~nm~ of 0.01, i.e., ∼10^7^ bacteria mL^-1^, and were mounted on agarose slabs (0.8% w/v agarose in H~2~O). Fluorescence microscopy was performed on a Zeiss AxioImager.M1 fluorescent widefield microscope equipped with Zeiss filter sets 38HE, 43HE, 46HE, 47HE, and 49 (BP 470/40-FT 495-BP 525/50, BP 550/25-FT 570-BP 605/70, BP 500/25-FT 515-BP 535/30, BP 436/25-FT 455-BP 480/40, and G 365-FT 395-BP 445/50, respectively), an Axiocam 506 and the software Zeiss Zen 2.3. For confocal microscopy, a Leica SP5 confocal laser scanning microscope equipped with a 405 nm UV laser, an Argon laser line 458, 476, 514 nm, and a diode-pumped solid-state laser line 561 nm and software Leica LAS AF (version 2.6.3.8173) was used. Suspensions containing six or seven different fluorescent protein-tagged *E. coli* were detected through confocal microscopy using sequential scanning mode. For six color mixtures consisting of mTB2, mTq2, mCl3, mO2, mSc, and mCa-expressing *E. coli*, a first scan using laser line 561 nm was used for emission windows of 570--599, 600--630, and 650--750 nm. Then, a second scan using laser lines 405, 458, and 476 nm were used for emission windows 440--460, 480--500, and 520--540 nm. For seven color mixtures consisting of mTB2, mTq2, sGFP2, sYFP2, mO2, mSc, and mCa-expressing *E. coli*, a first scan using laser line 561 nm was used for emission windows of 570--599, 600--630, and 650--750 nm. A second scan using line 514 nm was used for the emission windows 540--560 nm. A third scan using lines 405, 458, 476 nm, and were used for the emission windows 440--460, 480--500, and 520--540 nm.

All image analysis and processing were carried out in ImageJ/FIJI ([@B56]). Signal bleed-through was corrected using a channel subtraction method. First, individual channels were thresholded (ImageJ/Fiji threshold using Otsu) to produce binary images. Binary template images were then dilated (ImageJ/Fiji command dilate) to accommodate spherical aberrations and subtracted from channels with signal bleed-through. All channels were background subtracted.

Single-cell fluorescence was analyzed as described previously ([@B46]). In short, bacteria were mounted on an agar slab as described above and samples were analyzed using a Zeiss AxioImager.M1 at 100x magnification. Multichannel images were acquired using phase contrast and appropriate fluorescent filters (see above). Using ImageJ/Fiji, phase contrast channels were thresholded using standard settings and used as a mask to determine the mean fluorescence signal of individual particles in the respective fluorescent channels.

Results
=======

In this work, a total of 96 plasmids were constructed (Table [2](#T2){ref-type="table"}). The plasmids constitute three sets, including (*i*) 32 broad-host range plasmids based on the pBBR1 origin of replication, (*ii*) 32 suicide plasmids based on the R6K origin of replication, which are maintained solely in hosts carrying the π factor, and a Tn*5*-based transposon system, and (*iii*) 32 narrow host-range plasmids harboring a pSC101 temperature-sensitive origin of replication and the Tn*7*-based transposon system. Each set consists of plasmids that carry one of eight different fluorescent protein genes and one of four different combinations of antibiotic resistances. We used a simple naming convention and separated the plasmid into the pMRE13X-series, which all confer chloramphenicol resistance, the pMRE14X-series, which all confer gentamicin and chloramphenicol resistance, the pMRE15X-series, which all confer kanamycin and chloramphenicol resistance, and the pMRE16X-series, which all confer tetracycline and chloramphenicol resistance. The pFru97-based pMRE series contains an additional kanamycin resistance. Furthermore, we named plasmids based on the contained fluorescent protein, i.e., pMRE1X0 denotes mTagBFP2, pMRE1X1 denotes mTurquoise2, pMRE1X2 denotes sGFP2, pMRE1X3 denotes sYFP2, pMRE1X4 denotes mOrange2, pMRE1X5 denotes mScarlet-I, pMRE1X6 denotes mCardinal, pMRE1X7 denotes mClover3. Transposons are indicated as pMRE-Tn5-1XX for Tn*5* transposons and pMRE-Tn7-1XX for Tn*7* transposons.

Fluorescent protein-expressing bacteria were found to exhibit the expected fluorescence absorption and emission spectra (Figure [2](#F2){ref-type="fig"}) ([@B27]; [@B64]; [@B22]; [@B12]; [@B7]), suggesting that no changes in their spectral properties were introduced by cloning procedures. However, it was noticeable that bacterial cells harboring the pMRE14X-series exhibited increased fluorescence intensities than in the rest of the plasmid series, likely due to readthrough of the gentamicin promoter which was cloned upstream the fluorescent protein gene. Therefore, the fluorescence intensity of the pMRE-series carrying the mScarlet-I gene in combination with all antibiotic resistance genes was determined in *E. coli* DH5α. Additionally, the emitted fluorescence was assessed in four independent *E. coli* DH5α::MRE-Tn5-145 Tn*5* insertions mutants and four independent *E. coli* DH5α::MRE-Tn7-145 Tn*7* insertion mutants. Plasmids pMRE135, pMRE155, and pMRE165 led to similar fluorescence in *E. coli* DH5α, however, plasmid pMRE145 resulted in significantly brighter fluorescence intensities (Figure [3A](#F3){ref-type="fig"}). After Tn*5* and Tn*7* transposition, *E. coli* DH5α exhibited similar fluorescence intensities, however, transposon-conferred fluorescence intensities were signifi-cantly lower than plasmid-conferred fluorescence intensities (Figure [3B](#F3){ref-type="fig"}).

![Normalized **(A)** absorption and **(B)** emission spectra of the fluorescent proteins used in this work.](fmicb-09-03052-g002){#F2}

![**(A)** Fluorescence intensity of *Escherichia coli* DH5α cultures expressing mScarlet-I from different pMRE plasmid series (pMRE135, pMRE145, pMRE155, pMRE165). **(B)** Fluorescence intensity of mScarlet-I in plasmid-borne *E. coli* DH5α cultures (pMRE145), Tn*5-* and Tn*7*-insertion mutants. *E. coli* DH5α was used as control. One-way ANOVA and Tukey's *post hoc* test were used to infer statistical differences between groups. Letters indicate differences among means with a 99.99% confidence interval (*p* \< 0.0001). A.u., arbitrary units.](fmicb-09-03052-g003){#F3}

Plasmid Sets Are Broadly Transmissible Into a Variety of Proteobacteria
-----------------------------------------------------------------------

Plasmid functionality and fluorescence protein expression was tested in a phylogenetically broad range of bacteria that were previously isolated from plant leaves (Table [4](#T4){ref-type="table"}). The pMRE-series plasmids were successfully conjugated and maintained in *Sphingomonas melonis* FR1, *Erwinia amylovora* CFBP1430S, *Pantoea agglomerans* 299R, and *Pseudomonas syringae* B728a. Tn*5* transposon plasmid were delivered by conjugation and integrated into the genome of *Bradyrhizobium* sp. Leaf396, *Methylobacterium* sp. Leaf92, *S. melonis* FR1, *Sphingomonas phyllosphaerae* FA2, *E. amylovora* CFBP1430S, *P. agglomerans* 299R, and *Pseudomonas citronellolis* P3B5. Tn*7* transposon plasmids were delivered by conjugation and integrated into the genome of *S. melonis* FR1, *E. amylovora* CFBP1430S, and *P. agglomerans* 299R.

###### 

Bacterial strains used as recipients for conjugation of pMRE, pMRE-Tn5, and pMRE-Tn7.

  Class              Order                Family                Genus species                       pMRE   ::MRE-Tn5   ::MRE-Tn7
  ------------------ -------------------- --------------------- ----------------------------------- ------ ----------- -----------
  Actinobacteria     Actinomycetales      Microbacteriaceae     *Microbacterium* sp. Leaf320        No     No          No
  Actinobacteria     Actinomycetales      Nocardiaceae          *Rhodococcus* sp. Leaf225           No     No          No
  α-Proteobacteria   Rhizobiales          Rhizobiaceae          *Bradyrhizobium* sp. Leaf396        No     165         No
  α-Proteobacteria   Rhizobiales          Rhizobiaceae          *Methylobacterium* sp. Leaf92       No     165         No
  α-Proteobacteria   Sphingomonadales     Sphingomonadaceae     *Sphingomonas melonis* Fr1          145    145         145
  α-Proteobacteria   Sphingomonadales     Sphingomonadaceae     *Sphingomonas phyllosphaerae* FA2   135    145         No
  β-Proteobacteria   Burkholderiales      Comamonadaceae        *Acidovorax* sp. Leaf84             No     No          No
  γ-Proteobacteria   Enterobacteriales    Enterobacteriaceae    *Erwinia amylovora* CFBP1430S       135    145         145
  γ-Proteobacteria   Enterobacteriales    Enterobacteriaceae    *Pantoea agglomerans* 299R          135    145         145
  γ-Proteobacteria   Pseudomonadales      Pseudomonadaceae      *Pseudomonas citronellolis* P3B5    145    145         No
  γ-Proteobacteria   Pseudomonadales      Pseudomonadaceae      *Pseudomonas syringae* B728a        145    145         No
  Sphingobacteria    Sphingobacteriales   Sphingobacteriaceae   *Pedobacter* sp. Leaf194            No     No          No

The specific plasmids or transposons used for each strain are depicted by their ending (refer to Table

2

)

.

For a fast assessment of transposon-mediated insertions, multiplex PCRs were developed to amplify a region of the insert (i.e., fluorescent protein gene) and plasmid backbone simultaneously, i.e., a PCR on the donor plasmid resulted in two PCR products, while a genomic integration of the transposon resulted in only one PCR product. As expected, successfully integrated insertions into the genome of all tested strains were corroborated, as no plasmid backbone was detected whilst the fluorescent protein gene was correctly amplified (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}).

To test for stability and fitness cost of the plasmids and transposon insertions, populations of *P. agglomerans* 299R (*Pa*299R) wild type, *Pa*299R (pMRE), *Pa*299R::MRE-Tn5, and *Pa*299R::MRE-Tn7 were grown in rich media supplemented with or without chloramphenicol. The bacteria were then plated onto media containing antibiotics to detect subpopulations that lost their plasmid or transposon and differences in single cell fluorescence was assessed using fluorescence microscopy. Other than a reduction in the wild type *Pa*299R populations in presence of chloramphenicol, no statistical differences were found between the rest of the strains and growth conditions (Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}). In addition, fluorescence intensity of single cells was higher in *Pa*299R(pMRE135) compared to transposon insertion mutants in both growth conditions. Also, a decrease in fluorescence intensity in *Pa*299R(pMRE135) was observed when grown without chloramphenicol compared to the same strain grown with antibiotic pressure (Supplementary Figure [2B](#SM1){ref-type="supplementary-material"}), indicating that plasmid loss occurred. Fluorescence did not decline in Tn*5* or Tn*7* transposon mutants growing without antibiotic pressure, indicating that no loss of transposon insertions occurred.

The Provided Fluorescent Protein Toolbox Allows to Track Multiple Bacterial Strains in Parallel
-----------------------------------------------------------------------------------------------

Using standard fluorescence microscopy equipment, it was possible to track up to seven bacterial strains in parallel. Employing widefield fluorescence microscopy and widely distributed fluorescence filter sets (i.e., standard blue, green, and red fluorescence emission filters) three bacterial strains could be unambiguously identified, allowing to monitor three strains equipped with mTB2, mCl3, and mSc (Figure [4A](#F4){ref-type="fig"}), respectively. Less common combination of filters (i.e., blue, cyan, yellow, and red fluorescence emission filters) allows monitoring of up to four strains expressing mTB2, mTq2, sYFP2, and mSc, respectively (Figure [4B](#F4){ref-type="fig"}).

![Microscopy images of fluorescent bacteria. **(A)** Widefield epifluorescence micrograph of *E. coli* expressing either mTB2 (blue), mCl3 (green), or mSc (red). **(B)** Widefield epifluorescence micrograph of *E. coli* expressing either mTB2 (blue), mTq2 (cyan), sYFP2 (green), or mSc (red). **(C)** Confocal microscopy of a mixed *E. coli* expressing either mTB2 (blue), mTq2 (magenta), mCl3 (yellow), mO2 (green), mSc (white), or mCa (red). **(D)** Confocal microscopy of a mixed *E. coli* expressing either mTB2 (cyan), mTq2 (magenta), sGFP2 (yellow), sYFP2 (gray), mO2 (red), mSc (green), or mCa (blue). In all cases, *E. coli* harboring pMRE14X plasmids series were used. Scale bar: 10 μm.](fmicb-09-03052-g004){#F4}

Using filter free confocal laser scanning microscopy, it was possible to detect six different fluorescently tagged cell populations without further image processing (Figure [4C](#F4){ref-type="fig"}). After bleedthrough correction (see section "Materials and Methods," i.e., for sYFP2 and sGFP2, mO2 and mSc, and mSc and mCa) seven different fluorescently tagged cell populations could be distinguished (Figure [4D](#F4){ref-type="fig"}).

A Broad Host Range of Environmental Bacteria Express Fluorescent Proteins From Plasmids and Transposon Insertions
-----------------------------------------------------------------------------------------------------------------

All bacteria that were successfully equipped with plasmids or transposons (Table [4](#T4){ref-type="table"}) were grown on agar media plates and epifluorescence widefield microscopy was performed to determine fluorescence at the single-cell resolution. All bacterial strains exhibited fluorescence that could be determined at the single-cell resolution with a high signal-to-noise ratio (Figure [5](#F5){ref-type="fig"}). The range of fluorescence intensity of the environmental strains was comparable to *E. coli* DH5α and yielded signals in the same magnitude. In general, bacterial strains harboring pMRE-series plasmids showed higher variations in fluorescence intensity than Tn*5* and Tn*7* transposon mutants. Additionally, *P. syringae* B728a yielded an exceptionally bright signal compared to other bacterial strains (Figure [6](#F6){ref-type="fig"}).

![Widefield microscopy of environmental bacteria expressing fluorescent proteins. **(A)** *E. coli* DH5α (pMRE145). **(B)** *E. coli* DH5α::MRE-Tn5-145. **(C)** *E. coli* DH5α::MRE-Tn7-145. **(D)** *Bradyrhizobium* sp. Leaf396::MRE-Tn5-165. **(E)** *Methylobacterium* sp. Leaf92::MRE-Tn5-165. **(F)** *Sphingomonas melonis* FR1 (pMRE145). **(G)** *S. melonis* FR1::MRE-Tn5-145. **(H)** *S. melonis* FR1::MRE-Tn7-145. **(I)** *Sphingomonas phyllosphaerae* FA2 (pMRE135). **(J)** *S. phyllosphaerae* FA2::MRE-Tn5-145. **(K)** *Erwinia amylovora* CFBP1430S (pMRE135). **(L)** *E. amylovora* CFBP1430S::MRE-Tn5-145. **(M)** *E. amylovora* CFBP1430S::MRE-Tn7-145. **(N)** *Pantoea agglomerans* 299R (pMRE135). **(O)** *P. agglomerans* 299R::MRE-Tn5-145. **(P)** *P. agglomerans* 299R::MRE-Tn7-145. **(Q)** *Pseudomonas citronellolis* P3B5 (pMRE145). **(R)** *P. citronellolis* P3B5::MRE-Tn5-145. **(S)** *Pseudomonas syringae* pv. *syringae* B728a (pMRE145). **(T)** *P. syringae* B728a::MRE-Tn5-145. Exposure times used during image acquisition are depicted in the corresponding images. Scale bars represent 5 μm.](fmicb-09-03052-g005){#F5}

![Single-cell fluorescence intensity of bacterial strains expressing fluorescent proteins. Data were normalized by exposure time and expressed as milli arbitrary units.](fmicb-09-03052-g006){#F6}

Discussion
==========

A set of plasmids was constructed conferring eight fluorescent phenotypes in a wide range of bacteria. The fluorescent proteins used in this work were selected to have minimal spectral overlap, which allows parallel detection of up to four fluorescent proteins on a standard widefield microscopy system and seven fluorescent proteins on filter free confocal microscopy systems. Additionally, the series of plasmids and transposons carry four different antibiotic resistance combinations which allows the selection of bacterial mutants while accommodating their requirements of naturally-occurring antibiotic resistance.

The strong, constitutive promoter of the *nptII* gene is active in a wide range of taxa and has been shown to be suitable to drive fluorescent protein expression from single chromosomal insertions ([@B33]). All bacterial strains that carried either a plasmid of the pMRE-series, Tn*5* or Tn*7*-based transposons, exhibited visible fluorescence at a single-cell resolution. This shows the application of the here constructed toolbox and its potential use to generate fluorescently-tagged bacterial communities.

The plasmids were tested in a wide range of bacterial taxa that originated from aboveground surfaces of plants ([@B18]; [@B61]; [@B24]; [@B48], [@B47]; [@B3]; [@B57]). For efficient delivery of the plasmids, conjugation using *E. coli* S17-1 was performed. The presence of the *tra* operon in this strain allows for the mobilization of plasmids to recipient strains ([@B59]), bypassing the need to produce and optimize competent cells for every recipient strain used, which can be very time and labor intensive for strains that were recently isolated. However, optimization of conjugation conditions might be necessary to increase conjugation efficiencies.

pFru97-based pMRE plasmids could be conjugated into Pseudomonads and Enterobacteriaceae supporting previous findings (Table [4](#T4){ref-type="table"}) ([@B37]; [@B40]). In contrast to previous findings, the *Microbacterium* sp. Leaf320 tested in this study did not readily accept pMRE plasmids compared to other *Microbacterium* sp. tested previously ([@B34]). For short term studies, or providing that the pMRE plasmids are highly stable in the used bacterial strains, they could be advantageous to other systems, since fluorescence is generally higher than after chromosomal insertion (Figure [3B](#F3){ref-type="fig"} and Supplementary Figure [2](#SM1){ref-type="supplementary-material"}).

The delivery of fluorescent protein genes into bacterial isolates was most successful using the Tn*5* transposon compared to the other two delivery systems. Most members of the Proteobacteria, including members of the α- and γ-Proteobacteria, were integrating the Tn*5* transposon into their genome, which is in line with previous observations ([@B1]; [@B55]). The Tn*5* transposome system, employing Tn*5* transposase bound to transposon DNA flanked by Tn*5* inverted repeats, has been shown to be suitable to construct random insertion mutations in Gram-positive bacteria ([@B19]; [@B69]). Consequently, Tn*5* transposon integration was tested in Gram-positive bacteria as well. Since the purpose of the constructs described here is not to generate mutant libraries but to fluorescently tag bacteria, Tn*5* insertions at low frequencies would be sufficient to serve the purpose as a gene delivery tool. However, we failed to identify positive mutants in the two Gram-positive strains tested. Even though this strain selection is not exhaustive, the lack of evidence of plasmid-based Tn*5* transposon delivery into Gram-positive strains underlines the slim chances of successfully using the here proposed system in Gram-positives. In the future, additional plasmids will be developed to allow fluorescent protein gene delivery into Gram-positive bacteria. The here constructed plasmids will serve as a foundation for this work. Transposon mediated delivery tools such as Himar will be employed to deliver fluorescent protein genes to widened bacterial host range ([@B41]).

The functionality of Tn*7* transposons is well-documented in Proteobacteria. However, the here employed plasmid backbone has been predominantly used in *E. coli* and very close relatives such as *Salmonella* ([@B36]; [@B46]). In *E. coli*, pMRE-Tn7 plasmids are conditional suicide plasmids that fail to replicate when cells are cultivated at temperatures above 32°C. In other bacteria, this plasmid is a suicide plasmid and is not replicating. pMRE-Tn7 plasmids carry the complete Tn*7* transposase machinery *in cis* ([@B36]). This is a great advantage compared to classical Tn*7* systems, which usually involve helper plasmids that provide the transposase machinery *in* *trans* ([@B31]; [@B10]). As the transposon machinery has to be provided on a second plasmid, the probability for both plasmids to be electroporated or conjugated into the same target cell is expected to be lower than in the system established by [@B36]. Without having compared the systems of [@B31] and [@B10], we expect that transposon delivery will be more successful using the here used delivery system. Even though the delivery system has previously been used in Pseudomonads ([@B26]), to our knowledge, this is the first successful application of the system as a suicide plasmid in Enterobacteriaceae and *S. melonis* FR1 that do not replicate the plasmid backbone.

To determine the successful genomic integration of the Tn*5* or Tn*7* transposons, we provide a convenient PCR-based tool that allows for screening integration events. However, mapping of transposon insertion sites will be important if the aim of a study is functional studies, especially if the Tn*5* transposon system, which occur randomly in the bacterial genome and may disrupt essential genes of the studied species, is used. Due to this property, Tn*5* transposon systems have previously not only been used to deliver DNA fragments into bacterial species, but also to create mutant pools and transposon libraries for genome functional analyses ([@B71]; [@B20]). Thus, an arbitrary PCR as described by [@B14] should be performed. It is furthermore advisable to assess if there are any fitness differences between Tn*5* insertion mutants and wild type strains. In the case of Tn*7* transposition, insertions occur in specific attachment sites (*attTn7*), which have been mapped at the 3′ end of the *glmS* gene and has been shown to pose no fitness cost to the bacterial host ([@B17]; [@B36]).

Using standard epifluorescence widefield microscopy, we were able to distinguish four differentially labeled bacterial strains (Figure [4](#F4){ref-type="fig"}). Using less common fluorescent filters and/or spectral linear unmixing approaches ([@B73]), it should be possible to unambiguously identify five different fluorescently tagged populations. Next to *E. coli* DH5α, environmental strains also expressed fluorescent proteins to a similar degree that enabled observation of bacteria at the single-cell resolution (Figure [5](#F5){ref-type="fig"} and Supplementary Figure [2](#SM1){ref-type="supplementary-material"}).

Recently, many techniques have been developed to investigate fluorescently-tagged bacteria *in situ*, which for instance allowed the detection of 15 differentially tagged bacterial strains from dental plaques ([@B68]). In combination with other experimental advances such as removing autofluorescent background from environmental samples ([@B50]; [@B43]) and spatially explicit analysis of bacteria *in situ* ([@B13]; [@B58]), the here constructed molecular tools set the foundation to further advance *in situ* investigation of environmental bacteria.

We present a plasmid toolbox suitable to fluorescently label a broad range of bacteria for research in microbiology and microbial ecology that will be provided to the scientific community. The use of these plasmids will enable convenient tagging of many environmental bacteria and will thereby facilitate several disciplines of microbiology, such as single-cell microbiology, synthetic community, biofilm, host--microbe and microbe--microbe interactions. The ability to tag bacteria with unambiguous fluorescent colors in combination with antibiotic resistance markers to track bacterial population development at the single-cell resolution as well as on the whole population scale will be invaluable for many studies.

All plasmids constructed in this work have been made available in the convenient conjugation strain *E. coli* S17-1 that allows conjugation of the mobilisable plasmids into other bacteria at the non-profit plasmid repository Addgene^[2](#fn02){ref-type="fn"}^.
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Author Contributions
====================

RS constructed the pMRE-Tn*5* plasmid series, performed most other experiments, analyzed the data, and wrote the manuscript. HJ constructed the pMRE plasmid series. MB constructed the pMRE-Tn*7* plasmid series. SO performed genotyping PCRs. EB performed several mating experiments with γ-proteobacteria and contributed to other experiments. DM-L constructed pMRE134 and pMRE137. RD contributed materials and facilities. DR contributed to experiments, supervision, discussion, and writing. MR-E conceived and supervised the study, wrote the manuscript, contributed to some experiments, and analyzed data. All authors have read and approved the manuscript.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was funded by a seed grant of the Biomolecular Interaction Centre of the University of Canterbury to RD and MR-E and the Royal Society of New Zealand Marsden Fast Start grant (UOC1704) to MR-E. RS was supported by a NZIDRS doctoral scholarship. MB was supported by a University of Canterbury Doctoral Scholarship and a Biomolecular Interaction Centre doctoral scholarship.

Raphael Ledermann and Hans-Martin Fischer (ETH Zurich) are acknowledged for contributing to the construction of pMRE-Tn5-sYFP.

<https://www.fpbase.org/collection/78/>

<http://www.addgene.org>

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fmicb.2018.03052/full#supplementary-material>

###### 

Click here for additional data file.

[^1]: Edited by: Haiwei Luo, The Chinese University of Hong Kong, China

[^2]: Reviewed by: Yongtao Zhu, Minnesota State University, Mankato, United States; Beatriz Quiñones, United States Department of Agriculture -- Agricultural Research Service, United States

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Evolutionary and Genomic Microbiology, a section of the journal Frontiers in Microbiology
